|
BTBD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.089600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.718000E-01 |
| Normal-vs-Stage2 |
8.261400E-01 |
| Normal-vs-Stage3 |
9.261800E-01 |
| Normal-vs-Stage4 |
6.730400E-01 |
| Stage1-vs-Stage2 |
6.572400E-01 |
| Stage1-vs-Stage3 |
7.035000E-01 |
| Stage1-vs-Stage4 |
5.280600E-01 |
| Stage2-vs-Stage3 |
8.723000E-01 |
| Stage2-vs-Stage4 |
8.993600E-01 |
| Stage3-vs-Stage4 |
7.383000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.894000E-01 |
| Normal-vs-AfricanAmerican |
1.531030E-01 |
| Normal-vs-Asian |
6.773000E-01 |
| Caucasian-vs-AfricanAmerican |
1.846010E-01 |
| Caucasian-vs-Asian |
5.358800E-01 |
| AfricanAmerican-vs-Asian |
1.082640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.739800E-01 |
| Normal-vs-Female |
5.923600E-01 |
| Male-vs-Female |
1.065550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.762000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.301200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.602600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.671000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.766600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.402800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.830000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.955000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.009400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.632000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.601400E-01 |
| Classical-VS-Follicular |
7.370000E-04 |
| Classical-VS-Other |
1.270030E-01 |
| Classical-VS-Normal |
2.770400E-01 |
| Tall-VS-Follicular |
6.976100E-03 |
| Tall-VS-Other |
6.268300E-02 |
| Tall-VS-Normal |
1.030600E-01 |
| Follicular-VS-Other |
7.271000E-01 |
| Follicular-VS-Normal |
5.552400E-02 |
| Other-VS-Normal |
3.214400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.177400E-01 |
| Normal-vs-N1 |
1.604370E-01 |
| N0-vs-N1 |
3.398800E-01 |
|
|
